Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 10/29/2025 1:23:52 PM
Board Marks: 394
Posts Today: 0
Board Views Today: 1832
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
My69z
08/21/2025 3:18:45 AM
PD-L1 monitoring score card after
(6)
MJS719
08/21/2025 12:37:17 AM
A few other tidbits: Briefing book is
(18)
My69z
08/21/2025 12:04:36 AM
Dr. J confirms PD-L1 or PD-1 makes no
(10)
My69z
08/20/2025 11:58:49 PM
"...we been working with Cornell as I
(13)
generactor
08/20/2025 11:18:06 PM
Fantastic interview.
(21)
USS JOHNSTON
08/20/2025 11:12:40 PM
Excellent video! Some highlights after
(31)
twinter11
08/20/2025 9:29:59 PM
Dr. Jacob Lalezari, MD - CEO, CytoDyn -
(38)
MJS719
08/20/2025 7:49:08 PM
Interesting tidbit that I have no idea
(1)
sean007
08/20/2025 1:07:23 PM
IF we take last years date,...It is a
(4)
sean007
08/20/2025 12:42:06 PM
The window for asking for additional
(16)
brentie
08/20/2025 12:27:25 PM
In 2021 they had the meeting on
(9)
Katangolo
08/20/2025 11:51:02 AM
???? Core evidence of the unnamed tech
(27)
biloxiblues
08/20/2025 11:26:47 AM
Trying to solve the puzzle. With AI The
(18)
Katangolo
08/20/2025 11:07:32 AM
Here it is 9/30/2020
(8)
Katangolo
08/20/2025 11:05:35 AM
I just went on the CYDY website and
(9)
Katangolo
08/20/2025 10:06:19 AM
Wasnt manufacturing discussed a few
(19)
Katangolo
08/20/2025 9:57:56 AM
We had the annual meeting in September
(13)
My69z
08/20/2025 8:43:54 AM
Agree on pre-clinical affect & include
(18)
KenChowder
08/20/2025 8:28:16 AM
I was writing back and forth with
(28)
KenChowder
08/20/2025 6:29:10 AM
It doesn't have to take a long time for
(10)
docj
08/20/2025 6:17:29 AM
Thought I'd post this on IH since Ken
(12)
My69z
08/20/2025 3:42:11 AM
& Proxy is end of Nov..... You are
(8)
HouseofCards
08/19/2025 11:34:20 PM
I know we've heard rumors about quiet
(14)
My69z
08/19/2025 9:32:22 PM
Something big is going to develop
(6)
My69z
08/19/2025 5:09:25 PM
Feb. 6th, 2025: As the Company
(18)
Niele
08/19/2025 4:48:01 PM
It is my understanding that the S-3
(5)
USS JOHNSTON
08/19/2025 4:03:56 PM
Fly-on-the-Vancouver-wall Question:
(25)
misiu143
08/19/2025 3:13:33 PM
If dose will be change to 700 mg , all
(22)
HouseofCards
08/19/2025 2:37:54 PM
Something MGK and Ken were talking
(3)
Buddyboy20
08/19/2025 2:23:58 PM
I have read a little on SSAT and CCR5
(5)
Respert24
08/19/2025 1:51:36 PM
Its only a waste of time if you
(13)
dfwl28
08/19/2025 1:29:15 PM
Does LL positively impact enzyme SSAT?
(15)
Evil Rabbit
08/19/2025 12:43:30 PM
12 thumbs down. Thats impressive.
(10)
Evil Rabbit
08/19/2025 11:28:36 AM
Add the 30+ Ive deleted just this
(16)
waxonwaxoff
08/19/2025 11:23:26 AM
Have to agree. As much as I tried to
(10)
HHIGambler
08/19/2025 10:58:13 AM
My compassion ran out after I deleted
(11)
craigakess
08/19/2025 10:54:25 AM
The one thing I would say about Riz is
(9)
HHIGambler
08/19/2025 10:47:31 AM
He clearly has mental health issues. He
(11)
biloxiblues
08/19/2025 10:45:54 AM
Thank you to the Moderators. This
(8)
Evil Rabbit
08/19/2025 10:44:02 AM
Worst board member of all time and
(15)
HHIGambler
08/19/2025 10:40:22 AM
Can anyone with an ounce of sense
(11)
HHIGambler
08/19/2025 10:37:21 AM
You're reading 2-3 more words than me.
(11)
Evil Rabbit
08/19/2025 10:19:52 AM
MODS fingers must be blistered by
(13)
KenChowder
08/19/2025 7:23:45 AM
That's a good question, but we don't
(22)
My69z
08/19/2025 7:13:04 AM
Dec. 17th, 2024: If the RECOVER-TLC
(8)
MGK_2
08/19/2025 7:08:36 AM
I'd go along with that Ken, but tell me
(11)
KenChowder
08/19/2025 6:04:42 AM
MGK wrote: The two criteria that the
(25)
MGK_2
08/19/2025 5:05:16 AM
This is a more complete and concise
(11)
My69z
08/18/2025 9:59:11 PM
In progress: CRC 60 patient trial.
(11)
docj
08/18/2025 8:50:59 PM
I guess my initial reaction is... there
(11)
Newer
Older
Recent Articles
Electrolux Group Reports Positive Growth in Q3 2025 Results
Flow Traders Reports 3Q 2025 Results with Insights
Key Advantages of Cross-Straits Development for Unity
Electrolux Group Reports Strong Q3 Performance in 2025
Aker Horizons ASA Unveils Key Financials for Q3 2025
Electrolux Group Reports Strong Q3 Performance and Future Plans
Hikvision Launches Innovative AI Solutions to Support SMBs Growth
Revolutionizing AI Podcasts: The Soul App's New Voice Model
General Motors' Workforce Reductions and EV Market Challenges
Nobu Hospitality Expands Global Presence with Luxury Residences
United Imaging Healthcare Sees Growth in Q3 2025 Revenue
ING Achieves Impressive Results with €1.787 Billion Profit
Clariant Reports Growth in Q3 2025 EBITDA Margin Amid Challenges
Arcadis Q3 2025 Growth and Margin Expansion Overview
dsm-firmenich Delivers Promising Q3 2025 Update Insights
Pluxee Celebrates Strong Financial Performance for Fiscal 2025
Hansa Biopharma's Major Milestones and Financial Insights
Hansa Biopharma's Q3 Success and Future Growth Plans
Hansa Biopharma Shows Positive Progress with Imlifidase Trials
ING's Successful Share Buyback and New €1.6 Billion Plan
argenx Achieves Significant Milestones in Q3 2025
ING's Major Buyback and New Shareholder Distribution Plan
Jim Cramer Advocates Sharing Nvidia's Advanced Chips with China
Exploring the Expanding Horizons of Sustainable Materials Growth
The Future of Main Landing Gears Market and Industry Insights
Idorsia Reports Impressive Growth in QUVIVIQ Sales and Financials
argenx Excels with Strong Third Quarter Performance and Plans
Scatec Updates on Third Quarter Performance and Future Plans
PixVerse Partners with UNU Network to Promote AI for Good
United Imaging Healthcare's Revenue Growth Spikes in Q3 2025
Roche's Strategic Acquisition of 89bio: Making Waves in Biopharma
Nobu Hospitality Launches Exquisite Residences and Dining in Kuwait
Pluxee Announces Impressive Fiscal 2025 Performance Highlights
Pulsar Helium's Jetstream #3 Well Reaches Major Milestone
Arcadis Reports Q3 2025 Growth With Expanding Margins
Ontex's Q3 Results Show Strong Progress Despite Market Challenges
dsm-firmenich Reports Encouraging Q3 2025 Performance Insights
Clariant Reports Growth in EBITDA Margin amidst Challenges
EfTEN Real Estate Fund's Positive Growth Trajectory Unveiled
Telenor's Nordic Security Report Highlights Urgent Cyber Threats
TGS ASA Announces Ex-Dividend Trading at NOK 1.56 Today
Crédit Agricole S.A. Reports Strong Q3 and 9M 2025 Earnings
ING Reports Impressive €1.787 Billion Net Income for 2025 Q3
AI Computing Power: A Sustainable Solution for Retirement
Innovative Sugar Reduction Solutions Unveiled by Samyang Corp
Societe Generale Shows Impressive Financial Growth in Q3 2025
FMC Corporation Faces Significant Stock Decline After Earnings Report
Piramal Pharma Solutions Forms New Alliance with IntoCell
Piramal Pharma and IntoCell Collaborate for Advanced Bioconjugates
AI Computing Power: A Solution for America’s Retirement Dilemma